Pancreatic Cancer Research

ResearcherWashington University in St. LouisNo recent work listed

Feng Chen

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-2699-7190; OpenAlex author ID A5100352695.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Collaborators
5
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Co-author DOI 10.1038/s41588-022-01157-1↗
  2. Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study. Co-author DOI 10.1158/1078-0432.ccr-17-0492↗
  3. MicroRNA‑296 targets AKT2 in pancreatic cancer and functions as a potential tumor suppressor. Last author DOI 10.3892/mmr.2017.6602↗

Closest collaborators

The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Hailing Li · 1 shared paper, 2017
  2. Guoliang Qiao · 1 shared paper, 2017
  3. Herbert Kim Lyerly · 1 shared paper, 2017
  4. Ni Jiang · 1 shared paper, 2017
  5. Michael Andrew Morse · 1 shared paper, 2017

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.